Prospective Post-market Clinical Follow-up Study of the HBS 2 Resorb Mg in Patients With Intra- and Extraarticular Fractures, Pseudarthroses and Arthrodesis of Small Bones and Bone Fragments.

Inclusion Criteria: * Patient is 18 years and older * Patient is undergoing surgery with HBS 2 Resorb Mg * Written informed consent obtained for the treatment * Treatment of intra-articular and extra articular fractures and pseudarthroses of small bones and bone fragments as well as arthrodeses in the treatment of: * Scaphoid fractures and scaphoid pseudarthroses * Proximal radius head fractures * Fractures of the radial styloid process * Fractures of the ulnar styloid process * Metacarpal fractures * Metatarsal fractures Exclusion Criteria: * Any not medically managed severe systemic disease * Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment * Pregnancy or women planning to conceive within the study period * Persons who are legally detained in an official institution * Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study * Skeletally immature * Intraoperative decision to use implants other than the device under investigation